Compare Cipher Mining Inc (CIFR) vs Gilead Sciences, Inc. (GILD) Price & Performance

CIFR trades at $17.74, up 8.63% in the last session, but remains in a bearish technical trend with key support at $16. The company is transitioning from Bitcoin mining to AI data centers, reporting a Q2 2026 loss per share of $0.65, missing estimates. Revenue was $224 million in 2025 but fell to $191 million in 2026, with a net loss widening to $1.1 billion. Despite negative profitability metrics, analyst consensus is unanimously bullish with a $31.78 price target.

The outlook hinges on successful execution of its AI infrastructure pivot, offering growth potential but carrying high risk due to persistent losses, heavy capital expenditure, and reliance on project financing. Investors face volatility from operational cash burn and competitive pressures in the data center market, warranting caution despite optimistic Wall Street ratings.

Gilead Sciences (GILD) trades at $136.73, up 2.76% on the day, with a bullish technical signal and strong analyst consensus. Recent Q2 2026 earnings beat revenue estimates despite a net loss driven by acquisition costs, while HIV drug sales and raised guidance provide fundamental support. The stock is near its pivot point of $136, with resistance at $137 and support at $134.

Outlook remains positive given robust HIV franchise growth and pipeline advancements, but risks include patent cliffs, high debt, and profitability volatility. With 67% of analysts rating it a Buy and a consensus price target of $151.22, the stock offers potential upside, though investors must weigh execution risks against growth catalysts.